BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business Operations

  Aprea Therapeutics, Inc. reported financial results for the three months ended March 31, 2023 and provided a business update.

  May 15, 2023

   · 

  10 min read
• Business

  Aerovate Therapeutics Announces First Quarter 2023 Financial Results and Business Highlights

  Aerovate Therapeutics, Inc. announced financial results for the quarter ended March 31, 2023, and recent business highlights.

  May 15, 2023

   · 

  9 min read
• Business

  INVO Reports First Quarter 2023 Financial Results

  INVO Bioscience, Inc., a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture procedure it enables, announced financial results for the quarter ended March 31, 2023 and provided a business update.

  May 15, 2023

   · 

  12 min read
• Biotech Beach

  Arrowhead Pharmaceuticals to Participate in Upcoming May 2023 Conferences

  Arrowhead Pharmaceuticals, Inc. announced that it is scheduled to participate in the following upcoming investor events.

  May 15, 2023

   · 

  4 min read
• Business

  Celcuity Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Updates

  Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today reported financial results for the first quarter ended March 31, 2023 and provided other recent corporate updates.

  May 15, 2023

   · 

  11 min read
• Business

  OpGen Reports First Quarter 2023 Financial Results and Provides Business Update

  OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported its first quarter 2023 financial and operating results.

  May 15, 2023

   · 

  10 min read
• Business

  Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update

  Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”) today reported financial results and business updates for the first quarter of 2023.

  May 15, 2023

   · 

  15 min read
• Drug Development

  PaxMedica, Inc. Provides First Quarter 2023 Business Update; Phase 3 HAT-301 Top Line Results Expected in Second Half 2023

  PaxMedica, Inc. provided a business update and reported financial results for the first quarter 2023 ended March 31, 2023.

  May 15, 2023

   · 

  5 min read
• Business

  ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update

  ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, reported financial results for the three months ended March 31, 2023 and provided a business update.

  May 15, 2023

   · 

  11 min read
• Biotech Bay

  Cutera Cancels Special Meeting - May 15, 2023

  CUTERA, INC., a leading provider of aesthetic and dermatology solutions, announced that it has cancelled the Special Meeting of Stockholders previously scheduled for June 9, 2023.

  May 15, 2023

   · 

  3 min read